Citations

Showing 10 of 108094 citations.

Letter: Visual Field Defects in the Setting of Suprasellar Lesions: Could Vascularization Patterns of the Optic Chiasm Play a Role?
Agosti, Edoardo , Alexander, A. Yohan , Link, Michael J. , Meyer, Fredric B. , Peris‐Celda, Maria , Agosti, Edoardo , Alexander, A Yohan , Pinheiro‐Neto, Carlos

Mayo Clinic

Neurosurgery | June 21, 2022 | Volume: 91 | Issue: 3 | Pages: e102-e103

10.1227/neu.0000000000002069 | PMID 35876674 Get It

Commentary: Endoscope-Assisted Resection of a Frontotemporal Dermoid Cyst: 2-Dimensional Operative Video
Peña, Nicole M. De La , Patra, Devi Prasad, Bendok, Bernard R. , De La Peña, Nicole M, Bendok, Bernard R , De La Peña, Nicole M

Mayo Clinic

Operative Neurosurgery | June 21, 2022 | Volume: 23 | Issue: 1 | Pages: e77-e78

10.1227/ons.0000000000000240 | PMID 35726951 Get It

Endoscopic Transpterygoid Transcavernous Approach for Resection of a Petroclival Chondrosarcoma: 2-Dimensional Operative Video
Almeida, João Paulo , Andrade, Erion Júnior de , Woodard, Troy D. , Kshettry, Varun R. , Almeida, Joao Paulo , Sreenath, Satyan B , Recinos, Pablo F.

Mayo Clinic

Operative Neurosurgery | June 21, 2022 | Volume: 23 | Issue: 1 | Pages: e60-e61

10.1227/ons.0000000000000222 | PMID 35726942 Get It

Microsurgical Resection of a Petroclival Meningioma via a Suboccipital Approach: Technical Nuances and Anatomical Considerations: 2-Dimensional Operative Video
Turcotte, Evelyn L. , Zimmerman, Richard S. , Patel, Naresh P. , Pines, Andrew R. , Patel, Naresh P

Mayo Clinic

Operative Neurosurgery | June 21, 2022 | Volume: 23 | Issue: 1 | Pages: e55-e55

10.1227/ons.0000000000000197 | PMID 35726938 Get It

Spinal Compared with General Anesthesia in Contemporary Primary Total Hip Arthroplasties
Owen, Aaron R. , Amundson, Adam W. , Fruth, Kristin M. , Duncan, Christopher M. , Smith, Hugh M. , Johnson, Rebecca L. , Taunton, Michael J. , Pagnano, Mark W. , Berry, Daniel J. , Abdel, Matthew P. , Abdel, Matthew P , Johnson, Rebecca L , Taunton, Michael J , Berry, Daniel J , Fruth, Kristin M

Mayo Clinic

Journal of Bone and Joint Surgery | June 21, 2022 | Volume: 104 | Issue: 17 | Pages: 1542-1547

10.2106/jbjs.22.00280 | PMID 35726967 Get It

Background: The specific advantages of spinal anesthesia compared with general anesthesia for primary total hip arthroplasty (THA) remains unknown. Therefore, this study aimed to investigate the pain control, length of stay, and postoperative outcomes associated with spinal anesthesia compared with general anesthesia in a large cohort of primary THAs from a single, high-volume academic institution. Methods: We retrospectively identified 13,730 primary THAs (11,319 patients) from 2001 to 2016 using our total joint registry. Of these cases, 58% had general anesthesia and 42% had spinal anesthesia. The demographic characteristics were similar between groups, with mean age of 64 years, 51% female, and mean body mass index (BMI) of 31 kg/m 2 . Data were analyzed using an inverse probability of treatment weighted model based on a propensity score that accounted for numerous patient and operative factors. The mean follow-up was 6 years. Results: Patients treated with spinal anesthesia had lower Numeric Pain Rating Scale (NPRS) scores (p < 0.001) and required fewer postoperative oral morphine equivalents (OMEs) at all time points evaluated (p < 0.001). Patients treated with spinal anesthesia also had shorter hospital length of stay (p = 0.02), fewer altered mental status events (odds ratio [OR], 0.7; p = 0.02), and fewer intensive care unit (ICU) admissions (OR, 0.7; p = 0.01). There was no difference in the incidence of deep vein thrombosis (p = 0.8), pulmonary embolism (p = 0.4), 30-day readmissions (p = 0.17), 90-day readmissions (p = 0.18), all-cause revisions (p = 0.17), or all-cause reoperations (p = 0.14). Conclusions: In this large, single-institution study, we found that spinal anesthesia was associated with reduced pain scores and OME use postoperatively. Furthermore, spinal anesthesia resulted in fewer altered mental status events and ICU admissions. These data favor the use of spinal anesthesia in primary THAs. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Anemia Etiology and the Response to a Gluten-Free Diet in Untreated Patients With Celiac Disease: A 2-Year Follow-Up
Roldan, Giovanni A. , Urquiaga, Mariana, Dennis, Melinda, Leffler, Daniel A. , Kelly, Ciarán P. , Goyes, Daniela , Villafuerte-Gálvez, Javier , Murray, Joseph A.

Mayo Clinic

American Journal of Gastroenterology | June 21, 2022 | Volume: 117 | Issue: 10 | Pages: 1684-1692

10.14309/ajg.0000000000001875 | PMID 35973187 Get It

INTRODUCTION: Anemia and micronutrient deficiencies are common in newly diagnosed patients with celiac disease (CeD). We aim to determine the prevalence and etiology of anemia in a cohort of patients with CeD in the United States and examine the effect of a gluten-free diet (GFD) on the laboratory parameters related to anemia in CeD. METHODS: We analyzed a prospectively collected cohort of adults with biopsy-proven CeD followed in a specialized CeD center between January 2000 and June 2016. We used the level of hemoglobin (Hb) and micronutrients suggested by the World Health Organization to establish the diagnosis of anemia or deficiencies. Demographic data and laboratory parameters related to anemia and micronutrients were recorded at the time of diagnosis and on a GFD. A celiac expert nutritionist or gastroenterologist evaluated all patients. RESULTS: In 572 patients with laboratory evaluation before starting a GFD, approximately 25% presented with anemia at the time of diagnosis of CeD. Iron deficiency was present in 50.8% of the cohort and in 78.8% of the patients with anemia. Within the anemic population, 84.4% of female patients as compared with 58.3% of male patients ( P = 0.02) showed iron deficiency. Folate deficiency (23.2%), vitamin B12 deficiency (11%), and anemia of chronic diseases (7.8%) were also part of both sexes' anemia etiology. Of the initially anemic patients, 81% and 89% normalized their Hb levels within 1 year and 2 years of beginning a GFD, respectively. All patients received appropriate supplementation when needed. DISCUSSION: Approximately 25% of individuals have anemia at CeD diagnosis. The anemia etiology included iron deficiency, vitamin deficiencies, and anemia of chronic diseases. Most of the patients will normalize their Hb levels and the anemia laboratory parameters 1 year after starting a strict GFD.
How Do Prescribing Clinicians Obtain Consent to Initiate Gender-Affirming Hormones?
Blasdel, Gaines , Everhart, Avery , Amand, Colt St. , Gaddis, Monica, Grimstad, Frances , St Amand, Colt

Mayo Clinic

Transgender Health | June 21, 2022 | Volume: 8 | Issue: 6 | Pages: 526-533

10.1089/trgh.2021.0208 | PMID 38130984 Get It

Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana
Roberts, Lewis R. , Rivers, Brian M. , Yates, Clayton , Newman, Lisa A. , Sarkodie, Benjamin Dabo , Asare-Aboagye, Yaw, Adjei, Alex A. , Harris, Adalynn E, Awuah, Baffour, Roberts, Lewis R , Davis, Melissa

Mayo Clinic

The Oncologist | June 21, 2022 | Volume: 27 | Issue: 9 | Pages: 760-767

10.1093/oncolo/oyac109 | PMID 35726905 Get It

Abstract Cancer incidence is increasing worldwide and is a major cause of mortality. The relative magnitude of the increase is remarkably high in low human development index (HDI; 95%) and medium HDI (64%) countries. On the African continent, a corresponding increase in cancer burden is predicted, particularly for sub-Saharan Africa. Current epidemiologic data indicate that mortality rates of certain cancers, such as breast and cervical cancers, in sub-Saharan Africa are the highest in the world, and the cancer risks are broadly comparable to the risks in high-income countries, such as the United States and Europe. Although emerging data alludes to the unique genetic profile of cancer in African populations, most cancer therapies are introduced to Africa without confirmatory clinical trials. Therefore, there is an increasing need for clinical trials directed toward prevention, screening, diagnosis, and identification of innovative treatments in the African context. This review will discuss the increasing cancer burden in Africa, with a particular focus on Ghana, unmet clinical needs in cancer, current medical systems, clinical trial regulatory systems, and challenges to clinical trial recruitment.
Characteristics of chronic intestinal failure in the USA based on analysis of claims data
Mundi, Manpreet S. , Mercer, David F. , Iyer, Kishore , Zimmermann, L. Brøsted, Berner‐Hansen, Mark , Bishop, Joan, Seidner, Douglas L. , Seidner, Douglas L , Mundi, Manpreet S , Pfeffer, Daniel

Mayo Clinic

Journal of Parenteral and Enteral Nutrition | June 21, 2022 | Volume: 46 | Issue: 7 | Pages: 1614-1622

10.1002/jpen.2426 | PMID 35726729 Get It

Abstract Background This study investigated the prevalence, characteristics, and management of patients with chronic intestinal failure (CIF) in the United States in 2012–2020, based on parenteral support (PS) prescription claims and healthcare utilization. Methods Patients with CIF were identified from the Integrated DataVerse® claims database if they had at least two PS prescriptions within 6 months and a relevant diagnosis. Analysis included prevalence and characteristics of patients with CIF, their travel distance to receive PS prescriptions, and the distribution of PS providers and their prescribing history. Results Up to 24,048 patients with CIF were identified, equivalent to 75 patients per million. CIF affected people of all ages, being more prevalent in women than in men. Many providers signed PS orders for small patient groups over short time periods, whereas few providers signed PS orders for large patient groups long term, indicating a lack of centralization. The distribution of PS providers suggested a disparity in healthcare coverage in rural vs urban areas, leading to patients traveling considerable distances to receive PS prescriptions. This may be exacerbated by a decline of providers with expertise in CIF and nutrition. Conclusions Healthcare disparities for patients with CIF have likely been obscured by the lack of CIF‐specific diagnostic and procedure codes, obliging providers to code for their patients under other codes. Effective policy changes, including centralized care, revision of reimbursement models, and expansion of nutrition‐focused education in addition to the newly introduced International Classification of Diseases codes, are needed to provide the best care for patients.